Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Longevity by Design

Longevity by Design artwork

Longevity Genes, Blood Biomarkers of Aging, & Targeting Aging with Metformin with Dr. Nir Barzilai

Mar 6, 20241 hr 19 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Aging is inevitable, but can we influence how we age? In this episode of Longevity by Design, hosts Dr. Gil Blander and Ashley Reaver, MS, RD, CSSD, interview Dr. Nir Barzilai - the Director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging - during which he discusses groundbreaking research on aging. This is an enlightening discussion with Dr. Barzilai on factors influencing healthspan and lifespan, and the paradigm-shifting idea of targeting aging to extend healthspan and lifespan. He shares fascinating insights from his research on the influence of genetics and lifestyle on healthspan and lifespan, and blood biomarkers of aging. The conversation sheds light on the emerging scientific evidence and paradigm-shifting concept for medical interventions (gerotherapeutics) to extend healthspan and lifespan by targeting the underlying biology of aging. The episode wraps up with actionable insights for listeners interested in enhancing their healthspan and longevity. Dr. Barzilai discusses the importance of personalized health strategies, integrating cutting-edge research with everyday health practices while emphasizing the importance of a holistic approach. As a listener, you will leave equipped with knowledge and science-backed ways to navigate your personal health journey and help you live healthier longer. Timestamps: Introduction: 00:00-04:13 Why Dr. Barzilai’s studies centenarians and their children?: 04:14-10:07 Do centenarians live longer with poor health or live healthier longer? 10:08-13:07 Does becoming a centenarian have a strong genetic influence?: 13:08-15:41 How do growth hormone and IGF-1 affect healthspan and lifespan?: 15:32-23:39 What other genes affect healthspan and lifespan?: 23:40- 26:51 Does low IGF-1 negatively impact muscle and physical functioning?: 26:52-28:40 What are the effects of ethnicity and socioeconomic status on longevity: 28:41-30:57 What is the effect of lifestyle, nutrition, and exercise on the longevity of centenarians?: 30:58-34:07 Do women or men live longer?: 34:08-37:55 Why do women live longer than men?: 37:56-41:38 Biomarkers of aging and biomarkers of organ aging: 41:39-47:07 What is metformin, and what is the purpose of the TAME trial?: 47:08-51:37 Do you think metformin will improve healthspan and lifespan?: 51:38-54:20 Does metformin only improve blood glucose control, or does it benefit health and aging in other ways? 54:21-56:50 Is metformin good for older adults but not young adults?: 56:51-57:45 How does the combination of metformin and exercise impact muscle size (hypertrophy) and strength?: 57:46-01:00:45 Should everyone take metformin?: 01:00:46-01:03:13 Dr. Gil Blander’s and Dr. Nir Barzilai’s personal humorous anecdotes on exercise: 01:03:14-01:04:32 Is there a reason and explanation for why metformin did not show an effect on lifespan in mice in the Interventions Testing Program (ITP)?: 01:04:33-01:07:01 Are GLP-1 agonists beneficial for healthspan and lifespan?: 01:07:02-01:10:55 Are there tradeoffs with using GLP-1 agonists?: 01:10:56-01:11:43 What are the top 5 gerotherapeutic candidates for improving healthspan and lifespan?: 01:11:44-01:15:10 Dr. Nir Barzilai’s top tip for improving health: 01:15:11-01:19:29

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. EP #2: "Cancer Is a Disease of Mistakes" — Derek Chiang on AI, Personalized Medicine, and the Limits of Machine Learning

    Nov 11, 202654 minAudio

    In this episode of Longevity by Design, host Renée Deehan, VP of Science & Artificial Intelligence is joined by co-host Will Dzierson, VP of Product & Design, both at InsideTracker to welcome the guest Derek Chiang, VP...

    Credit the people on this episode

  2. LBD 2.0 EP #1: Why Scientific Validity Isn't Enough

    Oct 23, 202650 minAudio

    In this episode of Longevity by Design, host Renée Deehan, Senior VP of Science, AI & Product, is joined by Will Dzierson, VP of Product & Design, both with InsideTracker, to welcome Ohad Manor, VP of Computational and...

    Credit the people on this episode

  3. Do Longevity Supplements Really Work?

    Mar 30, 20261 hr 10 minAudio

    In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Andrea Maier, Professor in Medicine and Director of the NUS Academy for Healthy Longevity at the National University of Singapore’s School...

    Credit the people on this episode

  4. What Houses, Garbage, and Trucks Teach Us About Aging with Dr. Uri Alon

    Mar 28, 20261 hr 5 minAudio

    In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Uri Alon, Professor at Weizmann Institute of Science. They explore a systems view of aging that treats longevity as a solvable model, not a...

    Credit the people on this episode

  5. Born to Live Longer? Inside the Genetics and Biology of Centenarians

    Mar 26, 20261 hr 2 minAudio

    In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Paola Sebastiani, Professor of Biostatistics at Tufts Clinical and Translational Science Institute. They explore what centenarians reveal...

    Credit the people on this episode